Collectively, our data underscore the importance of EZH2-mediated SMAD3 K53/K333 methylation in metastasis and indicate that SMAD3 methylation might function as an important factor in predicting overall survival of patients with breast cancer. This evidence concerns the gene SMAD3 and breast carcinoma.